Roche's U.S. gRED research head to retire, be replaced by MIT's Regev

Roche said Monday it has hired a Massachusetts Institute of Technology (MIT) professor as the new head of the Swiss drugmaker's U.S. research arm that was responsible for some of the company's best-selling medicines of the last few decades.